NexImmune (NEXI) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free NEXI Stock Alerts $3.32 +0.20 (+6.41%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSpyre Therapeutics (NASDAQ:SYRE) and NexImmune (NASDAQ:NEXI) Head to Head Contrastamericanbankingnews.com - May 2 at 2:22 AMNEXI Stock Earnings: NexImmune Reported Results for Q4 2023investorplace.com - April 17 at 1:03 AMAcute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsighttheglobeandmail.com - April 16 at 12:07 AMPortage mulls company closure, pauses enrolment for lead clinical programmemsn.com - April 15 at 7:00 PMXilio fires 21% of its workforce and reprioritises pipelinemsn.com - April 2 at 4:55 PMNexImmune Announces New Offerings in Recent Press Releasemsn.com - February 7 at 3:58 PMNexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesmarkets.businessinsider.com - February 6 at 9:13 PMNexImmune Secures Funding Through Equity and Warrant Salesmsn.com - February 6 at 8:39 AMNexImmune Ends Stock Sale Agreement, Raises $5.1 Millionmsn.com - February 3 at 3:23 PMNexImmune slips after securities offeringmsn.com - February 2 at 6:34 PMNexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - February 2 at 6:34 PMmarketbeat.com - February 2 at 2:12 PMmarketbeat.com - January 31 at 10:09 AMmarketbeat.com - January 31 at 9:37 AMmarketbeat.com - January 30 at 2:34 PMmarketbeat.com - January 30 at 11:20 AMmarketbeat.com - January 30 at 10:23 AMmarketbeat.com - January 30 at 9:54 AMmarketbeat.com - January 29 at 12:15 PMNexImmune, Inc. Common Stock (NEXI)nasdaq.com - January 13 at 9:31 PMmarketbeat.com - January 10 at 9:37 AMNexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidationinvestorplace.com - January 9 at 1:04 PMmarketbeat.com - January 9 at 10:09 AMmarketbeat.com - January 9 at 9:47 AMmarketbeat.com - January 9 at 9:38 AMmarketbeat.com - January 5 at 9:36 AMNexImmune's future in limbo as Gaithersburg biotech extends liquidation votebizjournals.com - December 26 at 2:54 PMNexImmune, Inc. (NEXI) Stock Price, News, Quote & History - Yahoo Financeca.finance.yahoo.com - December 10 at 8:27 PMmarketbeat.com - December 4 at 9:35 AMmarketbeat.com - December 1 at 2:29 PMNEXI Stock Halted: What’s Going on With NexImmune Shares Today?investorplace.com - December 1 at 2:04 PMWhy Is NexImmune (NEXI) Stock Up 353% Today?investorplace.com - December 1 at 9:12 AMmarketbeat.com - December 1 at 8:26 AMNexImmune Inc Ordinary Shares NEXImorningstar.com - November 23 at 8:51 PMGaithersburg’s NexImmune prepares to shut down, lay off ‘substantially all’ employeesbizjournals.com - November 8 at 6:33 PMWhat's Going On With Neximmune (NEXI) Stock Monday?msn.com - November 6 at 1:14 PMWhy Neximmune (NEXI) Stock Is Getting Hammeredmsn.com - November 3 at 3:25 PMNexImmune Shares Slide Premarket as Biotech Says It Will Liquidatemarketwatch.com - November 3 at 10:24 AMmarketbeat.com - November 3 at 10:11 AMmarketbeat.com - November 3 at 9:59 AMmarketbeat.com - November 3 at 9:51 AMmarketbeat.com - November 3 at 9:37 AMNexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetesfinance.yahoo.com - October 24 at 10:14 AMNexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meetingfinance.yahoo.com - October 19 at 8:43 AMNexImmune, Inc.: NexImmune Announces 1-for-25 Reverse Stock Splitfinanznachrichten.de - October 18 at 2:14 PMNexImmune Announces 1-for-25 Reverse Stock Splitfinance.yahoo.com - October 18 at 2:14 PMEY report finds cracks in pharma supply chain operationsmsn.com - October 4 at 7:20 PMNexImmune to lay off over half of its employeesmsn.com - September 1 at 6:38 PMNexImmune announces 53% reduction in workforceseekingalpha.com - August 31 at 10:46 PMNexImmune to Cut Workforce by More Than Half to Reduce Costs, Extend Cashmarketwatch.com - August 31 at 5:45 PM Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. NEXI Media Mentions By Week NEXI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEXI News Sentiment▼0.000.43▲Average Medical News Sentiment NEXI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEXI Articles This Week▼11▲NEXI Articles Average Week Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Petros Pharmaceuticals News Today Exicure News Today Processa Pharmaceuticals News Today Longeveron News Today China Pharma News Today Oragenics News Today GT Biopharma News Today Seelos Therapeutics News Today Tharimmune News Today Bright Minds Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEXI) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
